Auxilius Secures €1.3M to Scale AI-Powered GRC Automation
Auxilius secured €1.3M to expand its AI-native GRC platform, automate compliance controls, and grow its engineering team.
Latest articles
Events
Startups
6 min
10 Global Startup and Tech Events to Watch This Summer
10 global startup events for founders to connect with investors, explore AI and tech trends, and expand across Europe, Asia, and North America.
AI
VC
1 min
Visiblie Secures €500K to Expand AI Visibility Platform for SMEs
Visiblie secured €500K to expand its AI visibility platform, grow its SME customer base, and accelerate international expansion.
Startups
VC
1 min
Alva Industries Secures €16M to Scale Electric Motor Technology
Alva Industries secured €16M to expand electric motor production and accelerate growth across robotics, aerospace, and industrial markets.
AI
VC
1 min
Luxonis Secures $14M to Scale Physical AI and Robotics
Luxonis secured $14M to expand its AI-powered robotics platform, scale production, and accelerate global growth in industrial automation.
AI
VC
1 min
Qolab Secures $54.2M to Advance Quantum Computing Technology
Qolab secured $54.2M to advance superconducting quantum computing, expand semiconductor partnerships, and accelerate fault-tolerant systems.
AI
Development
1 min
HTGF Appoints Two New Partners to Strengthen AI and Deep Tech Investments
HTGF promoted Johannes Weber and Axel Nitsch to lead investments in AI, Digital Tech, Climate Tech, and Deep Tech.
AI
Growth
1 min
inploi and Harri Partner to Improve AI-Powered Hospitality Hiring
inploi and Harri partnered to deliver AI-powered hiring journeys and improve candidate conversion for hospitality employers.
Cybersecurity
VC
1 min
Dawnguard Secures $3.3M to Expand AI-Powered Cybersecurity Platform
Dawnguard secured $3.3M to expand its AI-powered cybersecurity platform, accelerate product development, and grow internationally.
Health
VC
1 min
Telum Therapeutics Secures €18M to Advance Antimicrobial Therapies
Telum Therapeutics secured €18M to advance Phase 1 trials of antimicrobial therapies targeting drug-resistant bacterial infections.